Evidence map›Paper›PMID 21629240›Full record

ReviewNature reviews. Neurology2011

Genetic susceptibility to ischemic stroke.

James F Meschia, Bradford B Worrall, Stephen S Rich

Abstract readReview
In one paragraph

Review in Nature reviews. Neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effects ofBioscience reports · 2019
    Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Biomarkers and the outcomes of ischemic stroke.Frontiers in molecular neuroscience · 2023
    Review
  11. Review
  12. Genome-Wide Detection of mJournal of molecular neuroscience : MN · 2021
    Article
  13. Article
  14. Serum uric acid and risk of stroke: a dose-response meta-analysis.Journal of clinical biochemistry and nutrition · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Blood Pressure Control and Protection of the Aging Brain.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

James F MeschiaDepartment of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA. meschia.james@mayo.edu
Bradford B Worrall
Stephen S Rich
University of Virginia · USMayo Clinic · US

Funding

The NINDS International Stroke Genetics Consortium StudyU01NS069208 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI KITTNER, STEVEN J · 2010 to 2013
$9.4M
Siblings With Ischemic Stroke Study (SWISS)R01NS039987 · NINDS · MAYO CLINIC JACKSONVILLE · PI MESCHIA, JAMES F · 2000 to 2009
$9.2M
NINDS NIH HHS R01 NS039987NINDS NIH HHS R01 NS39987NINDS NIH HHS U01 NS069208
6 · The paper itself

Abstract

Clinicians who treat patients with stroke need to be aware of several single-gene disorders that have ischemic stroke as a major feature, including sickle cell disease, Fabry disease, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, and retinal vasculopathy with cerebral leukodystrophy. The reported genome-wide association studies of ischemic stroke and several related phenotypes (for example, ischemic white matter disease) have shown that no single common genetic variant imparts major risk. Larger studies with samples numbering in the thousands are ongoing to identify common variants with smaller effects on risk. Pharmacogenomic studies have uncovered genetic determinants of response to warfarin, statins and clopidogrel. Despite increasing knowledge of stroke genetics, incorporating this new knowledge into clinical practice remains a challenge. The goals of this article are to review common single-gene disorders relevant to ischemic stroke, summarize the status of candidate gene and genome-wide studies aimed at discovering genetic stroke risk factors, and to briefly discuss pharmacogenomics related to stroke treatment.

Indexed as

Genetic Predisposition to DiseaseAnemia, Sickle CellAnimalsCADASILFabry DiseaseGenome-Wide Association StudyHumansIschemiaPharmacogeneticsStroke

Identifiers

PMID21629240
PMCPMC3932660
OpenAlexW2017939367

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.